- Home
- GNFT vs ENX Comparison
GNFT vs ENX Comparison
Compare GNFT & ENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNFT
- ENX
- Stock Information
- Founded
- GNFT 1999
- ENX 2002
- Country
- GNFT France
- ENX United States
- Employees
- GNFT N/A
- ENX N/A
- Industry
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- ENX Finance/Investors Services
- Sector
- GNFT Health Care
- ENX Finance
- Exchange
- GNFT Nasdaq
- ENX Nasdaq
- Market Cap
- GNFT 190.6M
- ENX 175.5M
- IPO Year
- GNFT 2019
- ENX N/A
- Fundamental
- Price
- GNFT $3.59
- ENX $9.45
- Analyst Decision
- GNFT Strong Buy
- ENX
- Analyst Count
- GNFT 1
- ENX 0
- Target Price
- GNFT $13.00
- ENX N/A
- AVG Volume (30 Days)
- GNFT 6.8K
- ENX 25.4K
- Earning Date
- GNFT 09-19-2024
- ENX 01-01-0001
- Dividend Yield
- GNFT N/A
- ENX 3.94%
- EPS Growth
- GNFT N/A
- ENX N/A
- EPS
- GNFT 0.47
- ENX 0.16
- Revenue
- GNFT $86,225,222.00
- ENX N/A
- Revenue This Year
- GNFT $155.44
- ENX N/A
- Revenue Next Year
- GNFT N/A
- ENX N/A
- P/E Ratio
- GNFT $7.34
- ENX $61.00
- Revenue Growth
- GNFT 175.45
- ENX N/A
- 52 Week Low
- GNFT $3.31
- ENX $7.84
- 52 Week High
- GNFT $6.42
- ENX $10.07
- Technical
- Relative Strength Index (RSI)
- GNFT 33.70
- ENX 39.81
- Support Level
- GNFT $3.58
- ENX $9.49
- Resistance Level
- GNFT $3.90
- ENX $9.89
- Average True Range (ATR)
- GNFT 0.14
- ENX 0.12
- MACD
- GNFT 0.03
- ENX -0.01
- Stochastic Oscillator
- GNFT 3.08
- ENX 23.91
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.
About ENX Eaton Vance New York Municipal Bond Fund of Beneficial Interest $.01 par value
Eaton Vance New York Municipal Bond Fund is principally engaged in managing investment funds and providing investment management and advisory services to high-net-worth individuals and institutions. It is a non-diversified, closed-end investment company. Its objective is to provide current income exempt from regular federal income tax, including alternative minimum tax, and, in state specific funds, taxes in specified state.